{"meshTagsMajor":["Prostatic Neoplasms"],"meshTags":["5-alpha Reductase Inhibitors","Antineoplastic Agents, Hormonal","Diet, Fat-Restricted","Diet, Vegetarian","Enzyme Inhibitors","Finasteride","Genetic Therapy","Humans","Male","Neoadjuvant Therapy","Prostatectomy","Prostatic Neoplasms","Radiotherapy","Selenium","alpha-Tocopherol"],"meshMinor":["5-alpha Reductase Inhibitors","Antineoplastic Agents, Hormonal","Diet, Fat-Restricted","Diet, Vegetarian","Enzyme Inhibitors","Finasteride","Genetic Therapy","Humans","Male","Neoadjuvant Therapy","Prostatectomy","Radiotherapy","Selenium","alpha-Tocopherol"],"publicationTypes":["English Abstract","Journal Article","Review"],"abstract":"Basic, epidemiological and clinical issues to be solved on prostate cancer were discussed as a preface. Sharp increase of prostate cancer incidence in Asian countries, almost constant level of latent cancer are intriguing epidemiological and pathological issues. Treatment of locally advanced prostate cancer, hormone-refractory prostate cancer has been a long-standing clinical challenge. New radiotherapy is expected for further advancement. Heterogeneity, clonility, multiplicity of prostate cancer are interesting pathological challenges.","title":"[Prostate cancer. Introduction].","pubmedId":"15714965"}